Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesMale Breast Cancer Presenting as an Axillary Mass: A Case Report and Literature Review
Southern Medical Journal, 06/29/09
Schneider S et al. - The presentation of breast cancer in a male as a solitary axillary mass is very unusual. In general, though the disease presents later in men than in women, the presentation is essentially the same in either gender group. Late and/or atypical presentation, however, delays diagnosis and treatment and carries a much worse prognosis.
Related Articles
Male breast cancer: A population-based comparison with female breast cancer
Journal of Clinical Oncology, 12/11/09
Relevance Score: 74%
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09
Relevance Score: 74%
SULT1A1 R213H polymorphism and breast cancer risk: A meta-analysis based on 8,454 cases and 11,800 controls
Breast Cancer Research and Treatment, 12/07/09
Relevance Score: 72%
Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
British Journal of Cancer, 11/30/09
Relevance Score: 72%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Today in Men`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effect of Perceived Racial Discrimination on Bodily Pain among Older African American Men
Pain Medicine, 12/15/09
Male breast cancer: A population-based comparison with female breast cancer
Journal of Clinical Oncology, 12/11/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor